This is the Leser-Trélat sign in a man in his 60s who presented with more than 500 brown […]

Phase III study finds risk reduced by 52% compared with control group

Large-scale phase III study met all primary and secondary endpoints

Agreement will allow NICE to make ‘efficient and effective’ updates to recommendations in its guideline portfolio

Treatment could help 300,000 patients over three years

Biogen’s Aduhelm label far exceeds clinical trial population, study says. That could bring real-world surprises nhigginsdunn Wed, 09/01/2021 […]

Sanofi pulls Epilim website after U.K. regulator points out consumer complaint bbulik Wed, 09/01/2021 – 11:33

Merck’s Keytruda survives FDA scrutiny in bladder cancer, but ends up with a smaller label aliu Wed, 09/01/2021 […]

There is a clear link between taking antibiotics and an increased risk of developing colon cancer within the […]

Sequential treatment using antibiotics that are similar but swapped around frequently is an effective way to kill bacteria […]